Published in Tissue Eng Part B Rev on August 01, 2010
Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol (2012) 2.00
Effect of Short-Term Stimulation with Interleukin-1β and Differentiation Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with Osteoblasts. Biomed Res Int (2015) 1.38
Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev (2011) 1.37
Human early fracture hematoma is characterized by inflammation and hypoxia. Clin Orthop Relat Res (2011) 1.29
Composite transcriptome assembly of RNA-seq data in a sheep model for delayed bone healing. BMC Genomics (2011) 1.13
T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One (2012) 1.12
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2. Acta Biomater (2012) 0.93
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. J Clin Invest (2015) 0.91
CXCL12/CXCR4 signaling and other recruitment and homing pathways in fracture repair. Bonekey Rep (2013) 0.87
Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis. Tissue Eng Part B Rev (2015) 0.86
Accelerated calvarial healing in mice lacking Toll-like receptor 4. PLoS One (2012) 0.86
Inflammation, fracture and bone repair. Bone (2016) 0.85
The multifaceted role of the vasculature in endochondral fracture repair. Front Endocrinol (Lausanne) (2015) 0.85
Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma model. Cell Mol Immunol (2013) 0.84
Monitoring tissue inflammation and responses to drug treatments in early stages of mice bone fracture using 50 MHz ultrasound. Ultrasonics (2013) 0.82
Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response. EMBO Mol Med (2015) 0.82
Biological and molecular profile of fracture non-union tissue: current insights. J Cell Mol Med (2015) 0.81
Interactions between MSCs and immune cells: implications for bone healing. J Immunol Res (2015) 0.81
Tumor necrosis factor improves vascularization in osteogenic grafts engineered with human adipose-derived stem/stromal cells. PLoS One (2014) 0.81
Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds. J Biomater Sci Polym Ed (2013) 0.80
Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Healing. Pharmaceuticals (Basel) (2010) 0.80
Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery. J Mater Sci Mater Med (2012) 0.79
Student Award for Outstanding Research Winner in the Ph.D. Category for the 9th World Biomaterials Congress, Chengdu, China, June 1-5, 2012: The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A (2012) 0.79
CD133: enhancement of bone healing by local transplantation of peripheral blood cells in a biologically delayed rat osteotomy model. PLoS One (2013) 0.79
Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners. Front Pharmacol (2015) 0.78
Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain. Pain (2014) 0.78
Exposure to 100% Oxygen Abolishes the Impairment of Fracture Healing after Thoracic Trauma. PLoS One (2015) 0.78
How does the pathophysiological context influence delivery of bone growth factors? Adv Drug Deliv Rev (2014) 0.78
Distal radius fixation through a mini-invasive approach of 15 mm. PART 1: a series of 144 cases. Eur J Orthop Surg Traumatol (2013) 0.77
Immune modulation as a therapeutic strategy in bone regeneration. J Exp Orthop (2015) 0.77
Defective Bone Repair in C57Bl6 Mice With Acute Systemic Inflammation. Clin Orthop Relat Res (2016) 0.77
Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice. PLoS One (2016) 0.76
Hypoxia-induced HMGB1 in would tissues promotes the osteoblast cell proliferation via activating ERK/JNK signaling. Int J Clin Exp Med (2015) 0.76
Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing. PLoS One (2016) 0.76
Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles. PLoS One (2016) 0.76
A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients. Int J Mol Sci (2017) 0.75
Investigation of localized delivery of diclofenac sodium from poly(D,L-lactic acid-co-glycolic acid)/poly(ethylene glycol) scaffolds using an in vitro osteoblast inflammation model. Tissue Eng Part A (2014) 0.75
Anaesthetic management of forearm fractures using a combination of haematoma block and intravenous regional anaesthesia. Med J Armed Forces India (2016) 0.75
The haematoma and its role in bone healing. J Exp Orthop (2017) 0.75
Interleukin 1β and tumor necrosis factor α promote hFOB1.19 cell viability via activating AP1. Am J Transl Res (2016) 0.75
Molecular profiling of a simple rat model of open tibial fractures with hematoma and periosteum disruption. Exp Ther Med (2016) 0.75
Bone fracture healing in mechanobiological modeling: A review of principles and methods. Bone Rep (2017) 0.75
Enhanced Calvarial Bone Healing in CD11c-TLR4-/- and MyD88-/- Mice. Plast Reconstr Surg (2017) 0.75
Alteration of blood clot structures by interleukin-1 beta in association with bone defects healing. Sci Rep (2016) 0.75
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. PLoS One (2017) 0.75
T Lymphocytes Influence the Mineralization Process of Bone. Front Immunol (2017) 0.75
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92
Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity (2003) 3.14
Charité total disc replacement--clinical and radiographical results after an average follow-up of 17 years. Eur Spine J (2005) 2.75
New glucocorticoids on the horizon: repress, don't activate! J Rheumatol (2005) 2.70
Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci Transl Med (2013) 2.43
Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells (2007) 2.40
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest (2012) 2.38
A prospective, randomized study of computer-assisted and conventional total knee arthroplasty. Three-dimensional evaluation of implant alignment and rotation. J Bone Joint Surg Am (2007) 2.33
Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol (2008) 2.02
Cytokine expression in human osteoblasts after antiseptic treatment: a comparative study between polyhexanide and chlorhexidine. J Invest Surg (2014) 1.95
The surgical treatment of the lumbar disc prolapse: nucleotomy with additional transpedicular dynamic stabilization versus nucleotomy alone. Spine (Phila Pa 1976) (2005) 1.84
Tibio-femoral loading during human gait and stair climbing. J Orthop Res (2004) 1.83
Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone. J Rheumatol (2010) 1.78
Diagnosis of periprosthetic infection following total hip arthroplasty--evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res (2008) 1.60
Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res (2007) 1.59
Origin and functional activity of the membrane-bound glucocorticoid receptor. Arthritis Rheum (2011) 1.59
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet (2006) 1.55
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol (2007) 1.55
Stair climbing is more critical than walking in pre-clinical assessment of primary stability in cementless THA in vitro. J Biomech (2005) 1.54
Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells (2009) 1.54
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone (2008) 1.48
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nat Rev Rheumatol (2010) 1.48
The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther (2010) 1.47
Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res (2011) 1.46
The challenge of establishing preclinical models for segmental bone defect research. Biomaterials (2009) 1.43
Small improvements in mechanical axis alignment achieved with MRI versus CT-based patient-specific instruments in TKA: a randomized clinical trial. Clin Orthop Relat Res (2014) 1.40
Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci U S A (2009) 1.38
Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol (2006) 1.36
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood (2005) 1.34
Human early fracture hematoma is characterized by inflammation and hypoxia. Clin Orthop Relat Res (2011) 1.29
The initial phase of fracture healing is specifically sensitive to mechanical conditions. J Orthop Res (2003) 1.28
A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med (2012) 1.26
Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids (2007) 1.19
Initial vascularization and tissue differentiation are influenced by fixation stability. J Orthop Res (2005) 1.16
Validity of frozen sections for analysis of periprosthetic loosening membranes. Clin Orthop Relat Res (2009) 1.15
Timely fracture-healing requires optimization of axial fixation stability. J Bone Joint Surg Am (2007) 1.15
Architecture of the osteocyte network correlates with bone material quality. J Bone Miner Res (2013) 1.15
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis (2011) 1.15
Composite transcriptome assembly of RNA-seq data in a sheep model for delayed bone healing. BMC Genomics (2011) 1.13
Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep (2006) 1.12
Physiologically based boundary conditions in finite element modelling. J Biomech (2006) 1.12
What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury (2011) 1.12
The influence of locally applied platelet-derived growth factor-BB on free tendon graft remodeling after anterior cruciate ligament reconstruction. Am J Sports Med (2004) 1.11
Varus malalignment has no influence on clinical outcome in midterm follow-up after total knee replacement. Arch Orthop Trauma Surg (2010) 1.11
Instability prolongs the chondral phase during bone healing in sheep. Bone (2005) 1.10
The organization of the osteocyte network mirrors the extracellular matrix orientation in bone. J Struct Biol (2010) 1.10
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol (2010) 1.10
Where should implants be anchored in the humeral head? Clin Orthop Relat Res (2003) 1.09
Standardized AP radiographs do not provide reliable diagnostic measures for the assessment of acetabular retroversion. J Orthop Res (2012) 1.09
A survey of formal methods for determining the centre of rotation of ball joints. J Biomech (2005) 1.08
Osteoclastic activity begins early and increases over the course of bone healing. Bone (2005) 1.08
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Influence of changes in stem positioning on femoral loading after THR using a short-stemmed hip implant. Clin Biomech (Bristol, Avon) (2007) 1.06
Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One (2012) 1.05
Twenty-three neutrophil granulocytes in 10 high-power fields is the best histopathological threshold to differentiate between aseptic and septic endoprosthesis loosening. Histopathology (2009) 1.04
Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner. PLoS One (2012) 1.04
Tibio-femoral joint contact forces in sheep. J Biomech (2006) 1.04
Joint line elevation in revision TKA leads to increased patellofemoral contact forces. J Orthop Res (2010) 1.04
Dynamic stabilization adjacent to single-level fusion: part II. No clinical benefit for asymptomatic, initially degenerated adjacent segments after 6 years follow-up. Eur Spine J (2010) 1.04
Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur J Immunol (2008) 1.03
Circadian rhythms in rheumatology--a glucocorticoid perspective. Arthritis Res Ther (2014) 1.03
Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res (2011) 1.03
Dynamic stabilization adjacent to single-level fusion: part I. Biomechanical effects on lumbar spinal motion. Eur Spine J (2010) 1.03